Oncogenic BRAF Alterations and Their Role in Brain Tumors
Alterations of the v-raf murine sarcoma viral oncogene homolog B (BRAF) have been extensively studied in several tumor entities and are known to drive cell growth in several tumor entities. Effective targeted therapies with mutation-specific small molecule inhibitors have been developed and establis...
Main Authors: | Felix Behling, Jens Schittenhelm |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/6/794 |
Similar Items
-
Incidence of kiaa1549‐braf fusion gene in Egyptian pediatric low grade glioma
by: Hala Taha, et al.
Published: (2015-12-01) -
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors
by: Karisa C. Schreck, et al.
Published: (2019-08-01) -
Promises of targeted therapy for low grade gliomas in children
by: E. F. Valiakhmetova, et al.
Published: (2019-07-01) -
Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
by: Hiroyuki Takeda, et al.
Published: (2021-03-01) -
A novel GIT2-BRAF fusion in pilocytic astrocytoma
by: Jeffrey Helgager, et al.
Published: (2017-11-01)